Results 161 to 170 of about 32,631 (259)

3D Simultaneous Post-Contrast T1/T2 Mapping and Synthetic Multi-Contrast Late Gadolinium Enhancement at 0.55T: Validation in Porcine Myocardial Infarction Model. [PDF]

Invest Radiol
Si D, Varghese J, Littlewood SJ, Binzel K, Pervaiz S, Mergaye M, Khan M, Han Y, Kunze KP, Crabb MG, Simonetti OP, Prieto C, Botnar RM.   +12 more
europepmc   +1 more source

Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis

ESC Heart Failure, Volume 12, Issue 2, Page 809-818, April 2025.
Abstract Aims This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light‐chain amyloidosis (AL) and hereditary (ATTRv) and wild‐type transthyretin amyloidosis (ATTRwt)].
Alessia Argirò, Mattia Zampieri, Carlotta Mazzoni, Carlo Fumagalli, Michela Baccini, Alessandra Mattei, Alberto Cipriani, Laura De Michieli, Aldostefano Porcari, Gianfranco Sinagra, Marco Merlo, Giacomo Tini, Beatrice Musumeci, Domitilla Russo, Pier Filippo Vianello, Marco Canepa, Roberto Licordari, Gianluca di Bella, Claudio Rapezzi, Federico Perfetto, Francesco Cappelli   +20 more
wiley   +1 more source

The associations among genetic features, late gadolinium enhancement and prognosis in hypertrophic cardiomyopathy. [PDF]

Front Cardiovasc Med
Su W, Wu H, Chen C, Zhang H, Yu Q, Liang L, Huo Q, Lou H, Che B, Zhao Y, Dan J, Zhang H.   +11 more
europepmc   +1 more source

Late Gadolinium Enhancement and Higher Risk of Arrhythmias

Journal of the American College of Cardiology, 2011
Alter, Peter, Rupp, Heinz
openaire   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Clinical applications of co-registered myocardial T2 mapping and dual bright- and black-blood late gadolinium enhancement magnetic resonance imaging. [PDF]

Eur Heart J Imaging Methods Pract
de Villedon de Naide V, Gerbaud E, Richard T, Génisson T, Narceau K, Bazin C, Sridi S, Benlala I, Dournes G, Schmid AI, Beitzke D, Montaudon M, Stuber M, Cochet H, Bustin A.   +14 more
europepmc   +1 more source

Influence of Reader Expertise on Myocardial Infarction Detection: A Comparative Study of Dark-Blood and Bright-Blood Late Gadolinium Enhancement MRI. [PDF]

Invest Radiol
Martens B, van der Meulen LR, Crawley RJ, van Cauteren YJM, Smulders MW, Streukens S, Hendriks BMF, Houben IPL, Gommers S, Frey SM, Brandts L, Wildberger JE, Chiribiri A, Holtackers RJ.   +13 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Reproducibility of late gadolinium enhancement quantification techniques in ischemic and non-ischemic heart diseases (ReLate study). [PDF]

Front Cardiovasc Med
Gavrysh J, Reisdorf P, Hadler T, Mayr T, Ammann C, Gröschel J, Kuhnt J, von Knobelsdorff-Brenkenhoff F, Muehlberg F, Schwenke C, Fenski M, Schulz-Menger J.   +11 more
europepmc   +1 more source